for Sep 13, 2021 through Sep 19, 2021
For starters, this is not a “vaccine mandate.” Second, OSHA has been around for 50 yrs. addressing all sorts of infectious diseases, not to mention a emergency standard for healthcare employers. https://t.co/1GYTol45bB
— Jennifer 'pro-voting' Rubin (@JRubinBlogger) September 13, 2021
💥💥Super interesting!💥💥
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 18, 2021
Adding oral fosfomycin to antimicrobial salvage therapy clear bactremia in 2 cases of persistent/refractory VRE bacteremia probably by reducing intestinal enterococcal domination as an ongoing source of bacterial translocation https://t.co/DAZnnvsxFw
💥Another negative trial for Remdesivir💥
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 15, 2021
DisCoVeRy open label RCT >800 pts 40% on steroids
No clinical benefit was observed from the use of remdesivir in pts who were hospitalized w COVID-19, were symptomatic for more than 7 days&required oxygen supporthttps://t.co/G3iayqcFh0 pic.twitter.com/mNxz2C1TC7
ICYMI, here's a comprehensive review on mRNA vaccines for infectious diseases, including COVID-19, influenza, Ebola and respiratory syncytial virus https://t.co/ZdM1lJO4wO pic.twitter.com/pWLSjFt1sS
— Nature Reviews Drug Discovery (@NatRevDrugDisc) September 15, 2021
At least 26 states have passed laws that permanently curtail state and local officials' power to combat public health threats like the coronavirus, a @KHNews, @AP investigation has found. #UnderfundedUnderThreathttps://t.co/SZV0yuIe2I
— The Associated Press (@AP) September 15, 2021
French Professor Christian Perronne specializes in emerging infectious diseases. He said: “Unvaccinated people are not dangerous; vaccinated people are dangerous for others.” Watch, read 👇🏻https://t.co/zIrZFGFPsQ
— Nat (@Arwenstar) September 18, 2021
Whoa. I missed this. Did you?@American_Heart no longer recommends clinda for dental ppx. This is news to abx stewards everywhere! @SIDPharm @accpinfdprn #IDTwitter @idpharmd https://t.co/Lg9z4dX8IP pic.twitter.com/9tWBOLmf83
— Monica Mahoney (@mmPharmD) September 16, 2021
Anyone who does inpatient ID and tries to set up home IV antibiotic therapy will instantly recognize why daptomycin is far superior to vanco for patient satisfaction -- ESPECIALLY with vanco q8 hours. That's some kind of torturehttps://t.co/FL614DBxpk @mmPharmD pic.twitter.com/OlhuctDHgd
— Paul Sax (@PaulSaxMD) September 14, 2021
Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola | Antimicrobial Agents and Chemotherapy https://t.co/bhuVtUGQlp Excellent minireview on remdesivir and why it isn't the game changer we though it was.
— Carlos del Rio (@CarlosdelRio7) September 17, 2021
California has less #COVID19 transmission than any state in the US.
— MicrobesInfect (@MicrobesInfect) September 17, 2021
Besides mask mandates & other measures, the state's high level of vaccinations have helped.
Over 82% of Californians aged 12 & older have at least one dose of a #coronavirus vaccine.https://t.co/HmNxGG0ESa
At least 26 states have passed laws that permanently curtail state and local officials' power to combat public health threats like the coronavirus, a @KHNews, @AP investigation has found. #UnderfundedUnderThreathttps://t.co/iiMKyHn0y2
— The Associated Press (@AP) September 15, 2021
Great news for 🇺🇸 #InfectionPrevention!! @CDCgov to invest $2.1 billion into preventing infections
— Mike Stevens (@Dr_Mike_Stevens) September 17, 2021
This could be a game changer for many healthcare settings (LTC ++). Also includes 💰 for #AntimicrobialStewardship! https://t.co/jtUtgQeaQ8 @SHEA_Epi @RealTimeCOVID19 pic.twitter.com/eZvTFozUlB
At least 26 states have passed laws that permanently curtail state and local officials' power to combat public health threats like the coronavirus, a @KHNews, @AP investigation has found. #UnderfundedUnderThreathttps://t.co/wuWWx6d5MY
— The Associated Press (@AP) September 15, 2021
By 03-15-2021, very few mothers were able to get antenatal & postnatal care, & children have gone unvaccinated, raising the risk of future outbreaks of infectious diseases. This is @AbiyAhedAli’s healthcare plan for the #SaveChildrenOfTigray @RepKarenBass https://t.co/HaodIqakQe
— Kaleab Belay Nega (@kaleab_nega) September 18, 2021
Zinc is an essential mineral. It has long been known for its beneficial effects on immune health. On top of regulating immune function, zinc also aids in fighting infectious diseases like the flu and pneumonia. This is the zinc supplement I recommend: https://t.co/InqrRKdXLC #ad pic.twitter.com/ElDOVBRwVe
— conspiracybot (@conspiracyb0t) September 17, 2021
🆕💥💥Systematic Review and Meta-Analysis #JACnews @BSACandJAC
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 16, 2021
Efficacy of doxycycline Vs azithromycin for the treatment of rectal chlamydia
Doxycycline had a higher microbiological cure rate than azithromycin #doxynorris #IDTwitter #medtwitter #TwitteRx https://t.co/CBzCATDCqe
New research Article: #Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with #COVID19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial https://t.co/zZ6WcXF2Jm pic.twitter.com/KFXHs8bTGB
— The Lancet Infectious Diseases (@TheLancetInfDis) September 15, 2021
Singapore is moving schools online after a spike in cases even with 80% of adults vaccinated. Gotta vaccinate kids ASAP https://t.co/FbAEPRjZ1F
— Eli Perencevich, MD MS🧼 😷 (@eliowa) September 19, 2021
An accepted manuscript at Clinical Infectious Diseases has successfully cultured the COVID-19 virus from fine aerosol samples taken from mask-wearing patients.
— Ed Tubb (@EdTubb) September 15, 2021
It finds loose-fitting masks (eg surgical masks) offer only modest source control.https://t.co/7llMx0UxC0
New research Article: Safety and immunogenicity of an inactivated #COVID19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial https://t.co/K5HUdCT68i
— The Lancet Infectious Diseases (@TheLancetInfDis) September 16, 2021
New Personal View: Prevention of host-to-host transmission by #SARSCoV2 vaccines https://t.co/dy7mMumLQu
— The Lancet Infectious Diseases (@TheLancetInfDis) September 15, 2021
CDC to invest $2.1 billion in healthcare #InfectionControl to strengthen and equip state and other public health departments and other partner organizations in the fight against #COVID19 & other infectious diseases. https://t.co/kqynUiJRGj pic.twitter.com/DONHRtycpJ
— CDC (@CDCgov) September 17, 2021
“The Department of Defense (DoD) administers 17 different vaccines, as outlined in the Joint Instruction on Immunizations and Chemoprophylaxis (Secretaries of the Air Force, Army, Navy, and Transportation, 1995), for the prevention of infectious diseases…”https://t.co/2AJQR3Vej6
— Todd (@tc__todd) September 13, 2021
The future of the pandemic "is up to us"
— Meet the Press (@MeetThePress) September 19, 2021
Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, talks to Meet the Press about the mixed messaging over Covid booster shots.https://t.co/EcesQWbggO pic.twitter.com/Y1cH81X53P
Great article in the lancet today summarizing evidence around vax, showing overwhelming efficacy against severe, and good efficacy against any disease in gen pop. Also important that vaccines unavailable to the low income world have ZERO efficacyhttps://t.co/0pMZZHxzWv pic.twitter.com/6XUGEj4uoj
— Zain Chagla (@zchagla) September 13, 2021
🆕💥 Observational study @Crit_Care @martinhoenigl
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 16, 2021
In ICU patients with COVID-19 Acute Respiratory failure,antifungal prophylaxis(98% posaconazole) was associated with significantly reduced CAPA incidence, but this did not translate into improved survivalhttps://t.co/eupy48ZduL pic.twitter.com/j9bcxKNTZg
IDSA is encouraged by today’s announcement from @WhiteHouse on the allocation of more than $2 billion of American Rescue Plan funds to support infection prevention and efforts to combat antimicrobial resistance.
— IDSA (@IDSAInfo) September 17, 2021
Our statement: https://t.co/fBJ1m2R0es pic.twitter.com/FIcnhxSlng
Dr. Anthony Fauci, the director of the National Institute for Allergies and Infectious Diseases and a White House medical adviser, says that he supports mandating vaccinations for airline passengers. https://t.co/Rf9vkTS68a pic.twitter.com/vdjtjrKJ43
— FOX 13 News Utah (@fox13) September 14, 2021
New "Osterholm Update: COVID-19" podcast! @mtosterholm & @cvdall discuss various approaches across the globe to address the Delta variant, President Biden's new vaccine mandate, #COVID19 outbreaks in children and schools, and booster vaccine doseshttps://t.co/Ob2icvIpyL pic.twitter.com/5nkDkinvkg
— CIDRAP (@CIDRAP) September 16, 2021
.@ICPIC_meeting It’s poster tour time #ICPIC2021 with various themes: Antimicrobial stewardship ✅ #COVID19 among health workers ✅ Multi drug resistant organisms ✅ Long term care ✅ and much more https://t.co/u4TxhJaYzF pic.twitter.com/eWnJ5hYssY
— Prof Didier Pittet (@DidierPittet) September 15, 2021
Unvaccinated Covid-19 patients cost $5.7 billion for treatment in the last 3 months, study estimates. Study by @KFF Cost of treating COVID-19 hospitalizations among unvaccinated was $0.6B in June; $1.4B in July & $3.7B in Sept. https://t.co/jq2ChrGPf8
— Carlos del Rio (@CarlosdelRio7) September 14, 2021
⛔Are you aware of this important interaction?, not in lexicomp⛔
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 14, 2021
Broad-spectrum azoles and flucloxacillin: a dangerous match
Flucloxacillin ⬇️ the level of voriconazole or Isavuconazole, we need TDM #IDTwitter #medtwitter #TwitteRx https://t.co/ElbmRvWQFm
Here is the article. https://t.co/XM0rsRPEA7
— Carl T. Bergstrom (@CT_Bergstrom) September 16, 2021
Aging is associated with a higher burden of some antibiotic resistance genes, including especially proteobacterial genes encoding multidrug efflux pumps. @mSphereJ https://t.co/uoQLY7YmeR pic.twitter.com/WNXx1uFIMn
— ASM (@ASMicrobiology) September 16, 2021
After the announcements in the UK and probably in the USA, as well as plans for a fourth dose in Israel. I think the world is making it's choice to the question. And it's sad to see. https://t.co/IvWpbnQcOk pic.twitter.com/szkOcoxOtG
— Zain Chagla (@zchagla) September 15, 2021
CID: A 5-day course of #remdesivir was associated with approximately 17-fold increased odds of survival among 54 nursing home residents with SARS-CoV-2 infection during an outbreak from October to December 2020.
— IDSA (@IDSAInfo) September 16, 2021
📄: https://t.co/4Mb8xCOL04 #IDSAJournals #ClinInfectDis pic.twitter.com/5MWHFiqWtU
For the first time, scientists identify a bacterium capable of both Fe(II) oxidation and Fe(III) reduction at circumneutral pH. Learn more in @JournalSpectrum: https://t.co/pbZP2a5dnt pic.twitter.com/gAfQQDFLP7
— ASM (@ASMicrobiology) September 13, 2021
One week to go!
— IAVI (@IAVI) September 16, 2021
Are you a researcher looking to upgrade your knowledge & skills in the field of infectious diseases?
Register today for @IAVI DataSpace learning series and access sessions on #epidemiology, genomics, immunology & #vaccine design.
Visit https://t.co/rq0enDeWek pic.twitter.com/Sa5lRkMPhl
SHEA is thrilled to see NHSN funding – one of our long-standing advocacy goals - modernizing how the US captures & analyzes infection data, drives improvements, & stops the spread of deadly pathogens. @CDCgov #InfectionPrevention #AntimicrobialStewardship https://t.co/4tm9sHkUTs
— SHEA (@SHEA_Epi) September 17, 2021
Antibiotic stewardship programs remain a priority for IDSA. IDSA supports several proposed revisions to @TJCommission's #antibioticstewardship requirements for hospitals and provides additional recommendations: https://t.co/Nb11y43KRM pic.twitter.com/gQhj3Ao5YH
— IDSA (@IDSAInfo) September 16, 2021
Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization (Mar 11–Aug 15, 21) was ⬆️for @moderna_tx (93%) than @pfizer (88%) and @JNJNews vaccine (71%).
— Carlos del Rio (@CarlosdelRio7) September 17, 2021
Optimizing antimicrobial use: challenges, advances and opportunities https://t.co/pDfCImoly8 #DHPSP #Precisionantimicrobialdose #antimicrobialstewardship #antimicrobialresistance
— RONITA DE (@dronita_de) September 17, 2021
A study of Italy-bound passengers found that a mandatory PCR #coronavirus test taken within 3 days of flying weeded out the vast majority of travelers with #COVID19https://t.co/6OewVj7XCI #travel
— MicrobesInfect (@MicrobesInfect) September 19, 2021
Did Remdesivir fail?! Why it's still in the NIH/IDSA guidelines?
— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) September 17, 2021
🆕💥💥Minireview #AAC @ASMicrobiology
Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola. #IDTwitter #medtwitter #TwitteRx https://t.co/NzVoJSeF2b
.@WHO calls on world leaders at the UN General Assembly to focus on vaccine equity, pandemic preparedness, and getting the SDGs back on track https://t.co/mTIgKhstC5 > 5.7 billion vaccine doses have been administered globally, but 73% have been administered in just 10 countries.
— Carlos del Rio (@CarlosdelRio7) September 19, 2021
Find your copy of the National Antimicrobial Stewardship Newsletter here. Alot is being done in the AMR space in Uganda.@fredkitutuhttps://t.co/KunjvKipAW https://t.co/g579yFkuo5 pic.twitter.com/WkeVTeBT2m
— Stella Nanyonga (@StellaNanyonga) September 13, 2021
Resistance to copper, which is mobilized to the urine as a host response during urinary tract infections, is a fitness factor for MRSA during infection. @mBioJournal https://t.co/noCp3mcaeU pic.twitter.com/crSPeKSJPJ
— ASM (@ASMicrobiology) September 14, 2021
“This measure can immediately decrease new infections, thereby alleviating pressure on hospitals, while avoiding widespread lockdowns, now and in the future," the letter from 65 infectious diseases physicians reads. https://t.co/B7m9UwKKGW
— Global Edmonton (@GlobalEdmonton) September 13, 2021
The @ECDC_EU are running a short e-learning course on antimicrobial stewardship as an approach to address healthcare-associated infections. Read more https://t.co/XwlPzv4mnE
— NHS European Office (@NHSConfed_EU) September 16, 2021
Toxoplasmosis may have a protective effect against the development of #MultipleSclerosis (MS), according to a review study.
— MicrobesInfect (@MicrobesInfect) September 13, 2021
People who had been infected with #Toxoplasma gondii were 32% less likely to develop MS than those who never had #toxoplasmosis.https://t.co/nRBOgILt1U
What if 1 airborne particle was enough to infect you? For some diseases, exposure to a single viral, bacterial or fungal particle can be infectious. When this happens, predicting airborne infections is easier. Now, a new theory of airborne disease spread https://t.co/2GjWUqLQzm
— delthia ricks 🔬 (@DelthiaRicks) September 16, 2021
Created by Cameron Forbes. Last updated September 20, 2021 at 05:16 EST.